The Bhiwadi Finished Dosage Forms (FDF) plant has successfully obtained global accreditations from the Agency for the Development of the Pharmaceutical Industry (ABD) in the Philippines and the Center for State Control of Medicines, Equipment, and Medical Devices (CECMED) in Cuba.
Medicamen Biotech Ltd (MBL) has filed its first Abbreviated New Drug Application (ANDA) in eCTD format for ‘BORTEZOMIB FOR injection 3.5 MG/VIAL” with the US Food and Drug Administration (USFDA). This accomplishment marks a significant milestone for the company, and is expected to prompt a USFDA audit in the future.
Copyright © 2023, MEDICAMEN BIOTECH LIMITED. All Rights Reserved. Designed by Rautela Tech